Aged, 80 and overMiddle AgedAfrican AmericansEuropean Continental Ancestry GroupUnited StatesChanges in the use of radical prostatectomy for treating prostate cancer in the USA. By - Ray M Merrilldoi:10.1016/S0140-6736(05)65380-9Ray M Merrill...
More than 80% of patients diagnosed with lung cancer, for example, present with metastatic disease. Nanotechnology is not alien to the clinic; more than 40 nanotherapeutics have reached patients, including anticancer drugs and imaging agents. Many current therapies are not reaching the sites of ...
Harisinghani, M. G. et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.N. Engl. J. Med.348, 2491–2499 (2003).Iron oxide nanoparticles have evolved over time into effective tools for imaging the spread of metastatic cancer. ArticlePubMedGoogle Scholar ...
Prostate cancer (PC) is a leading cause of death in older men. Androgen deprivation therapy (ADT) is considered the standard-of-care for men with locally advanced disease. However, continuous androgen ablation is associated with acute and long-term adverse effects and most patients will eventually...
Moreover, it highlights the physical and pharmacological properties that enhance their anti-metastasis efficiency. This review also addresses the combination of nanovaccines with cancer immunotherapy to target various steps in the metastatic cascade, drawing insights from preclinical and clinical studies. ...
Cristian Massacesi, Senior Vice President, Head of Late-Stage Development, Oncology R&D said: “Over the past few years, the outlook for breast cancer patients withBRCAmutations has radically changed, and the OlympiA data at ASC...
The present invention provides a new method for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating prostate cancer.
1. A method of treating prostate, ovarian, or breast cancer in a subject in need thereof, comprising administering an effective amount of a refined, whole leech saliva extract to the subject, the extract having a peptide molecular weight distribution with molecular weights of 3496 Daltons or grea...
The present invention relates to prostate cancer markers, compositions comprising such markers, and methods of using such markers to induce or increase an immune response against prostate cancer. An immune response against the markers correlates with an immune response, in particular a humoral immune ...
if diagnosis of prostate cancer is established at an early stage, a significant treatment effect can be expected such that a 10 years survival rate approaches to 80%. As a method for treating prostate cancer, pharmacotherapy, surgical therapy, radiotherapy, and hormone therapy are known in the ...